Abstract Although early therapeutic research on psychedelics dates back to the 1940s, this field of investigation was met with many…
Abstract The prevalence of depression is increasing worldwide, as is the number of people suffering from treatment-resistant depression; these patients…
Abstract Major depressive disorder is a high-impact, debilitating disease and it is currently considered the most prevalent mental illness. It…
Abstract Patients with a serious mental illness often use cannabis at higher rates than the general population and are also…
Abstract Altered activity of fatty acid amide hydrolase (FAAH), an enzyme of the endocannabinoid system, has been implicated in several…
Abstract Cannabis and analogs of Δ9-tetrahydrocannabinol have been used for therapeutic purposes, but their therapeutic use remains limited because of…
Abstract Background: Severe mental illness (SMI), including schizophrenia, bipolar disorder and severe depression, is responsible for a substantial proportion of…
Abstract Psychiatric disorders such as schizophrenia and major depressive disorder were thought to be caused by neurotransmitter abnormalities. Patients with…